Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/1999
03/02/1999US5877281 Since del-1 is expressed in endothelial cells and certain cancer cells, it may be useful as an endothelial cell and tumor marker. in addition, the ability of del-1 protein to inhibit vascular formation provides for its use as an
03/02/1999US5877275 Recombinant peptide containing the a domain of human cd11b capable of antagonizing cd11/cd18 mediated immune response; treat burns, frostbite, acute arthritis, asthama, respiratory distress syndrome; antiischemic agents
03/02/1999US5877155 Exposure of platelets to the molecule (anti-mimotope) in order to modulate adhesion, aggregation, or agglutination of the platelets.
03/02/1999US5877151 Depending on the dose or concentration of endotoxin, the effects may either be deleterious or advantageous to the host. if excessive tnf-.alpha.,il-1, il-6, and il-8 are produced, they can evoke endotoxic (or septic) shock with symptoms
03/02/1999US5877016 Human trk receptors and neurotrophic factor inhibitors
03/02/1999US5877015 APP770 mutant in alzheimer's disease
03/02/1999US5877006 DNAs encoding chimeric immunoglobulin light or heavy chains and fragments thereof having variable regions derived from monoclonal antibody 7E3, and vectors and host cells comprising same
03/02/1999US5877001 Polynucleotide encoding thermostable enzyme isolated from thermococcus; for removal of l-arginine, l-phenylalanine, or l-methionine from n-terminal of peptides in peptide synthesis reactions when ester functionality is present
03/02/1999US5876997 Phytase
03/02/1999US5876974 Method for producing DNA encoding cystic fibrosis transmembrane conductance regulator (CFTR) protein in E. coli
03/02/1999US5876973 Method for making antibodies which specifically bind to glial growth factors
03/02/1999US5876972 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
03/02/1999US5876969 Fusion polypeptide of therapeutic polypeptides attatched to c-and n-terminals of human serum albumin; for high plasma stability, minimization of dosage, side effect reduction
03/02/1999US5876967 Fibroblast growth factor homologous factor-2 and methods of use
03/02/1999US5876966 Compounds and methods for the stimulation and enhancement of protective immune responses and IL-12 production
03/02/1999US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle
03/02/1999US5876963 Human nucleotide pyrophosphohydrolase
03/02/1999US5876961 Production of antibodies
03/02/1999US5876950 Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
03/02/1999US5876949 Immunoglobulins binding to epitopes on proteins not fmr1; immunoassays using antibodies against fmr1 protein for diagnosis of genetic disorders
03/02/1999US5876947 Monospecific antibody reactive with Fibrinogen and fibrinopeptide B
03/02/1999US5876925 Generating bacteriophage display library expressing heterologous protein which bonds antigen on magnetically labeled cells; incubating with labeled and unlabeled cells, separating out label cells, isolating dna
03/02/1999US5876919 Incubating compound with tub protein in vitro, detection of complex formed; for modulators of obesity, cachexia, and other eating disorders
03/02/1999US5876917 Dendritic cell-specific antibodies and method for their preparation
03/02/1999US5876732 Envelope protein
03/02/1999US5876731 Candidate vaccines against hiv-1 and which are useful in diagnostic application.
03/02/1999US5876730 Heparin-binding growth factor (HBGF) polypeptides
03/02/1999US5876726 Vaccines and methods for preventing and treating fescue toxicosis in herbivores
03/02/1999US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition
03/02/1999US5876718 Using antibodies which bind to protein
03/02/1999US5876717 Prevent rejection of organ transplantation and also to cure autoimmune diseases.
03/02/1999US5876716 Aids therapy
03/02/1999US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/02/1999US5876708 Allogeneic and xenogeneic transplantation
03/02/1999US5876691 Screening a bacteriophage library; diagnosis of colorectal tumors
03/02/1999CA2242315A1 Mecb
03/02/1999CA2242252A1 Dexb
03/02/1999CA2241417A1 Novel ffh
03/02/1999CA1340417C Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
03/02/1999CA1340414C Inactivation of human immunodeficiency virus (hiv) in protein-containing solutions by phenols
03/01/1999CA2242311A1 Novel compounds
02/1999
02/28/1999CA2241427A1 Novel pyrr homolog
02/28/1999CA2241424A1 Novel ftsy
02/28/1999CA2241420A1 Novel folc
02/28/1999CA2241400A1 Ftsy
02/27/1999CA2233681A1 Novel div1b
02/26/1999CA2241431A1 Novel spoiiie
02/26/1999CA2241410A1 Pth
02/25/1999WO1999009411A1 NOVEL COMPOUND 2-AMINO-3-[2-(α-MANNOPYRANOSYL)INDOL-3-YL]PROPIONIC ACID, PROCESS FOR PREPARING THE SAME, AND METHOD FOR INSPECTING FUNCTION OF LIVING BODY WITH THE NOVEL COMPOUND
02/25/1999WO1999009199A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
02/25/1999WO1999009197A1 Methods and compositions for cloning nucleic acid molecules
02/25/1999WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999WO1999009182A2 Rab proteins
02/25/1999WO1999009177A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus
02/25/1999WO1999009176A1 Neisseria lactoferrin binding protein
02/25/1999WO1999009172A1 Method for identifying and locating expressed epil peptides, coded by the insl4 gene and their uses
02/25/1999WO1999009171A1 Ubc7-like ubiquitin-conjugating enzyme
02/25/1999WO1999009170A1 High affinity immunoglobulin e receptor-like protein
02/25/1999WO1999009168A1 Testis-specific transcription factor zgcl-1
02/25/1999WO1999009166A2 Prostate tumor polynucleotide and antigen compositions
02/25/1999WO1999009165A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof
02/25/1999WO1999009164A1 Coding sequence haplotypes of the human brca2 gene
02/25/1999WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999WO1999009159A1 Scavenger receptor-like proteins
02/25/1999WO1999009157A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY
02/25/1999WO1999009156A2 Protease-related protein
02/25/1999WO1999009155A1 70 human secreted proteins
02/25/1999WO1999009153A1 ISOLATION AND EXPRESSION OF A DISABLED PROTEIN GENE mDabl AND METHODS
02/25/1999WO1999009152A1 Human frezzled-like protein
02/25/1999WO1999009146A1 Human serum inducible kinase (snk)
02/25/1999WO1999009140A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
02/25/1999WO1999009064A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules
02/25/1999WO1999009063A1 Interleukin-18 binding proteins, their preparation and use
02/25/1999WO1999009058A1 Isolated osteocalcin fragments
02/25/1999WO1999009055A2 Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
02/25/1999WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
02/25/1999WO1999009049A1 Hypoxia-regulated genes
02/25/1999WO1999009047A1 Detection and treatment of breast, gynecological and prostate cancer
02/25/1999WO1999009046A1 Hypoxia-regulated genes
02/25/1999WO1999008712A2 METHOD FOR INFLUENCING THE p53 LINKAGE IN TARGET GENES
02/25/1999WO1999008708A2 Method and food product for increasing muscle protein and reducing fat in animals
02/25/1999WO1999008707A1 Preventives and/or remedies for systemic lupus erythematosus containing anti-il-6 receptor antibody as the active ingredient
02/25/1999WO1999008539A1 Novel phytase
02/25/1999WO1999008522A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
02/25/1999WO1998049317A3 Diagnosis and treatment of phosphatase- 0r kinase-related disorders
02/25/1999WO1998037418A3 Compounds for immunodiagnosis of prostate cancer and methods for their use
02/25/1999DE19837664A1 New antibodies against bi:cyclic pyrazine derivatives
02/25/1999DE19837391A1 Monoclonal antibody specific for dihydropyrimidine dehydrogenase
02/25/1999DE19756214C1 New chimeric human cytomegalovirus (HCMV) polypeptides
02/25/1999CA2301801A1 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
02/25/1999CA2301796A1 70 human secreted proteins
02/25/1999CA2301374A1 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999CA2301332A1 Neisseria lactoferrin binding protein
02/25/1999CA2301202A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof
02/25/1999CA2301154A1 Method for identifying and locating expressed epil peptides, coded by the insl4 gene and their uses
02/25/1999CA2301138A1 High affinity immunoglobulin e receptor-like protein
02/25/1999CA2301043A1 Testis-specific transcription factor zgcl-1
02/25/1999CA2300964A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
02/25/1999CA2300918A1 Ubc7-like ubiquitin-conjugating enzyme
02/25/1999CA2300805A1 Polypeptide having a gtpase regulator activity, nucleic acids coding therefor and their use in diagnostics and therapy